Yaskawa Electric Shares Slide as Weak Profit Overshadows Strong AI Demand 
SEB Q2 Profit Rises on Strong Lending, Record Fee Income, Announces New Share Buyback 
Australia Flags Child Safety Gaps at Apple, Meta, Google Over Online Sexual Extortion 
Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX 
ASML Raises 2026 Outlook as AI Chip Demand Lifts Q2 Earnings 
Rio Tinto Reports Strong Q2 Iron Ore Sales, Maintains 2026 Production Outlook 
SK Hynix Stock Soars as AI Memory Demand Outlook Fuels Chip Rally 
Taiwan Mangoes Head to Europe as Premium Fruit Exports Expand 
BHP Faces Major Port Hedland Strike as Labor Talks Stall Ahead of Production Report 
Alibaba Stock Jumps as China Approves Apple Intelligence Powered by Qwen AI 
Arm Stock Falls After HSBC Downgrade, Citing Limited Near-Term AI Upside 
DeepSeek Eyes China IPO as AI Startup Seeks $71 Billion Valuation in New Funding Round 
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business 
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors 
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report 
SoftBank Corp Partners With Sierra to Expand AI Customer Support Across Japan 
Richemont Q1 Sales Beat Forecast as Cartier Demand Drives Strong Growth 
FORT MYERS, Fla., Jan. 12, 2016 (GLOBE NEWSWIRE) -- 21st Century Oncology Holdings, Inc. (the "Company"), the largest global, physician-led provider of integrated cancer care services, commented today on recently passed legislation ahead of its presentation at the 34th Annual J.P. Morgan Healthcare Conference on January 12th, 2016 at 1:30pm PT / 4:30pm ET, where it will discuss the benefits of this new bill.
The United States Congress unanimously passed the Patient Access and Medicare Protection Act (S. 2425) which freezes radiation oncology freestanding payment rates for treatment delivery and image guidance codes in 2017 and 2018 at levels set for 2016. CMS will transition to a new episodic alternative payment model in 2019. The codes in the bill that are expressly protected are G6001 to G6015, which include IMRT, conformal and IGRT treatment. The bill was signed into law by President Obama on December 28, 2015.
The legislation also requires the Secretary of Health and Human Services (HHS) to submit to Congress a report on the development of an episodic alternative payment model for reimbursement under the Medicare program within 18 months.
Dr. Daniel Dosoretz, Founder, Chief Executive Officer and President, commented, “We applaud Congress and President Obama for their dedication to working together with the industry to advance payment reform and achieve payment predictability while ensuring patient access to quality cancer care. This is an exceptional example of how bipartisan collaboration can deliver a meaningful benefit to patients in need of the most advanced technologies available in radiation therapy. We look forward to working with policymakers over the next few years on developing an alternative payment model which will provide continued access to sophisticated radiation therapy treatment for patients for years to come.”
About 21st Century Oncology Holdings, Inc.
21st Century Oncology Holdings, Inc. is the largest global, physician led provider of integrated cancer care services. The Company offers a comprehensive range of cancer treatment services, focused on delivering academic quality, cost-effective patient care in personal and convenient settings. As of September 30, 2015, the Company operated 182 treatment centers, including 146 centers located in 17 U.S. states and 36 centers located in seven countries in Latin America.
21st Century Oncology Contact: LeAnne M. Stewart Chief Financial Officer 239-931-7281 [email protected] Investor Contact: The Ruth Group Nick Laudico 646-536-7030 [email protected] Brandon Vazquez 646-536-7032 [email protected]
